APA (7th ed.) Citation

T, d. V., E, R., A, v. d. B., R, D., AHJ, D., J, S., . . . A, M. (2024). Pharmacology of erenumab in human isolated coronary and meningeal arteries: Additional effect of gepants on top of a maximum effect of erenumab. British journal of pharmacology, 181(12), 1720. https://doi.org/10.1111/bph.16322

Chicago Style (17th ed.) Citation

T, de Vries, Rubio-Beltrán E, van den Bogaerdt A, Dammers R, Danser AHJ, Snellman J, Bussiere J, and MaassenVanDenBrink A. "Pharmacology of Erenumab in Human Isolated Coronary and Meningeal Arteries: Additional Effect of Gepants on top of a Maximum Effect of Erenumab." British Journal of Pharmacology 181, no. 12 (2024): 1720. https://doi.org/10.1111/bph.16322.

MLA (9th ed.) Citation

T, de Vries, et al. "Pharmacology of Erenumab in Human Isolated Coronary and Meningeal Arteries: Additional Effect of Gepants on top of a Maximum Effect of Erenumab." British Journal of Pharmacology, vol. 181, no. 12, 2024, p. 1720, https://doi.org/10.1111/bph.16322.